Pharmacelera plans to open US headquarters by early 2023
Pharmacelera planearía la apertura de una sede en Estados Unidos a principios de 2023
Intel ID : 355345
|
||||
| Intel ID | 355345 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Pharmacelera
(31 Dec 2021) |
Revenue: EUR 0,91m Net Debt: EUR 2,44m People: 12 |
|
| Date |
 |
|
| Country | |
|
| Geography |  |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
40.03.07 IT Consulting, Development & Outsourcing (Primary) 40 Information Technology / 40.03 Internet, Software & IT Services |
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
40.03.07 IT Consulting, Development & Outsourcing 40 Information Technology / 40.03 Internet, Software & IT Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.